Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.

Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I.

Arthritis Res Ther. 2010;12(2):R53. doi: 10.1186/ar2964. Epub 2010 Mar 24. Erratum in: Arthritis Res Ther. 2010;12(3):402.

2.

Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.

Shin MS, Lee N, Kang I.

Curr Opin Rheumatol. 2011 Sep;23(5):444-8. doi: 10.1097/BOR.0b013e328349a255. Review.

3.

IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.

Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D.

Autoimmun Rev. 2015 May;14(5):370-5. doi: 10.1016/j.autrev.2014.12.009. Epub 2014 Dec 23. Review.

PMID:
25541082
4.

Th1 and Th17 cells: adversaries and collaborators.

Damsker JM, Hansen AM, Caspi RR.

Ann N Y Acad Sci. 2010 Jan;1183:211-21. doi: 10.1111/j.1749-6632.2009.05133.x. Review.

5.

Interleukin-17 and systemic lupus erythematosus: current concepts.

Nalbandian A, Crispín JC, Tsokos GC.

Clin Exp Immunol. 2009 Aug;157(2):209-15. doi: 10.1111/j.1365-2249.2009.03944.x. Review.

6.

IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.

Weyand CM, Younge BR, Goronzy JJ.

Curr Opin Rheumatol. 2011 Jan;23(1):43-9. doi: 10.1097/BOR.0b013e32833ee946. Review.

7.

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus.

Chen J, Wu M, Wang J, Li X.

J Immunol Res. 2015;2015:206731. doi: 10.1155/2015/206731. Epub 2015 Dec 24. Review.

8.

Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Espinosa V, Rivera A.

Cytokine. 2012 Apr;58(1):100-6. doi: 10.1016/j.cyto.2011.11.005. Epub 2011 Nov 30. Review.

9.

The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Goropevšek A, Holcar M, Avčin T.

Clin Rev Allergy Immunol. 2017 Apr;52(2):164-181. doi: 10.1007/s12016-016-8550-y. Review.

PMID:
27216430
10.

Type 17 T helper cells-origins, features and possible roles in rheumatic disease.

Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S.

Nat Rev Rheumatol. 2009 Jun;5(6):325-31. doi: 10.1038/nrrheum.2009.80. Review.

PMID:
19434074
11.

Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.

Samson M, Audia S, Martin L, Janikashvili N, Bonnotte B.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S65-73. Epub 2013 Apr 19. Review.

PMID:
23663684
12.

Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity.

Morita K, Okamura T, Sumitomo S, Iwasaki Y, Fujio K, Yamamoto K.

Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii76-ii81. Review.

PMID:
27856665
13.

Anti-cytokine therapy in systemic lupus erythematosus.

Smolen JS, Steiner G, Aringer M.

Lupus. 2005;14(3):189-91. Review.

PMID:
15807194
14.

IL-23 and IL-17 in tuberculosis.

Khader SA, Cooper AM.

Cytokine. 2008 Feb;41(2):79-83. doi: 10.1016/j.cyto.2007.11.022. Epub 2008 Jan 22. Review.

15.

Systemic lupus erythematosus in the light of the regulatory effects of galectin-1 on T-cell function.

Hornung Á, Monostori É, Kovács L.

Lupus. 2017 Apr;26(4):339-347. doi: 10.1177/0961203316686846. Epub 2017 Jan 18. Review.

PMID:
28100106
16.

Role of IL-17 and Th17 cells in liver diseases.

Hammerich L, Heymann F, Tacke F.

Clin Dev Immunol. 2011;2011:345803. doi: 10.1155/2011/345803. Epub 2010 Dec 15. Review.

17.

Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus.

Rother N, van der Vlag J.

Front Immunol. 2015 Nov 30;6:610. doi: 10.3389/fimmu.2015.00610. eCollection 2015. Review.

18.

Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.

Klarquist J, Zhou Z, Shen N, Janssen EM.

Mediators Inflamm. 2016;2016:5045248. doi: 10.1155/2016/5045248. Epub 2016 Mar 30. Review.

19.

T cells as a therapeutic target in SLE.

Comte D, Karampetsou MP, Tsokos GC.

Lupus. 2015 Apr;24(4-5):351-63. doi: 10.1177/0961203314556139. Review.

20.

Increased serum IL-10 in lupus patients promotes apoptosis of T cell subsets via the caspase 8 pathway initiated by Fas signaling.

Yang X, Sun B, Wang H, Yin C, Wang X, Ji X.

J Biomed Res. 2015 May;29(3):232-40. doi: 10.7555/JBR.29.20130037. Epub 2014 Jun 21. Review.

Supplemental Content

Support Center